Protalix BioTherapeutics Inc. (DE) (PLX): SEC Form 3 filed by new insider Ben Zvi Shmuel
Stocks in this Quantisnow insightHealth Care
Keep researching PLX
- PLX insider tradesEvery buy and sale reported by Protalix BioTherapeutics Inc. (DE) officers, directors and large holders.
- What is Form 3?The initial SEC statement of beneficial ownership filed by a company's officers, directors and 10% holders when they first become insiders.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- PLX earnings historyPast Protalix BioTherapeutics Inc. (DE) earnings releases, newest first.
- PLX financial statementsRevenue, profit, cash flow and balance sheet from Protalix BioTherapeutics Inc. (DE)'s SEC filings.
Quantisnow market dataAMEX
PLX
Protalix BioTherapeutics Inc. (DE)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for PLX
Full PLX profile on Quantisnow Follow PLX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time